Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer

Clinical trial NCT00077363 · COMPLETED

Trial details

NCT number: NCT00077363
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Breast Cancer Stage IV Breast Cancer

Start date: 2004-05-01
Primary completion: 2007-02-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.